E-Qure Corp. focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. E-Qure Corp. is based in New York, New York.
Industry, Sector and Symbol
Industry Miscellaneous durable goods
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone972-5442-7777
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1
Next Earnings DateN/A
OptionableNot Optionable
E-QURE (OTCMKTS:EQUR) Frequently Asked Questions
What is E-QURE's stock symbol?
E-QURE trades on the OTCMKTS under the ticker symbol "EQUR."
Has E-QURE been receiving favorable news coverage?
Media coverage about EQUR stock has been trending positive recently, according to InfoTrie. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. E-QURE earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for E-QURE.
Who are some of E-QURE's key competitors?
Some companies that are related to E-QURE include SunLink Health Systems (SSY), Arca Biopharma (ABIO), NeuroVive Pharmaceutical (NEVPF), BENITEC BIOPHAR/S (BNTC), Navidea Biopharmaceuticals (NAVB), Sonoma Pharmaceuticals (SNOA), Genetic Technologies (GENE), Aevi Genomic Medicine (GNMX), Hemogenyx Pharmaceuticals (HEMO), Synthetic Biologics (SYN), Trillium Therapeutics (TRIL), Tenax Therapeutics (TENX), Capricor Therapeutics (CAPR), Integrated BioPharma (INBP) and ENDRA Life Sciences (NDRA).
What other stocks do shareholders of E-QURE own?
Who are E-QURE's key executives?
E-QURE's management team includes the folowing people:
- Mr. Ohad Goren, CEO & Director (Age 48)
- Mr. Gal Peleg, Chief Financial Officer (Age 41)
- Mr. Itsik Ben Yesha, CTO & Director (Age 66)
- Mr. Itai Weisberg, Chief Marketing Consultant
How do I buy shares of E-QURE?
Shares of EQUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is E-QURE's stock price today?
One share of EQUR stock can currently be purchased for approximately $0.06.
How big of a company is E-QURE?
What is E-QURE's official website?
How can I contact E-QURE?
E-QURE's mailing address is 20 WEST 64TH STREET SUITE 39G, NEW YORK NY, 10023. The company can be reached via phone at 972-5442-7777.
MarketBeat Community Rating for E-QURE (OTCMKTS EQUR)
MarketBeat's community ratings are surveys of what our community members think about E-QURE and other stocks. Vote "Outperform" if you believe EQUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EQUR will underperform the S&P 500 over the long term. You may vote once every thirty days.
